palpable tumor in nudes

Slides:

Advertisements

Similar presentations

P-4E-BP1/4E-BP1P-p70 S6K/p70 S6K ND cleaved PARP/PARPLC3II/LC3I Supplementary Figure 1 Relative levels A BC P-Akt/Akt.

Advertisements

P247. Figure 9-1 p248 Figure 9-2 p251 p251 Figure 9-3 p253.

Supplementary Figures&Legends. Figure1. Subcutaneous xenograft tumor models of the control group.

WEEK 1 You have 10 seconds to name…

To Find the Cancer Staging Tool, click on “Go To” and then chose “Cancer Staging”

Supplementary Figure 1: Correlation analysis of DKC1 mRNA and dyskerin protein quantity in neuroblastoma cell lines.

Development of novel therapeutic agents for neuroblastoma through iron and cholesterol metabolisms study Sang Y. Lee, Ph.D. Assistant Professor Department.

Bmi-1 Is Essential for the Tumorigenicity of Neuroblastoma Cells

TUMOR PD-L1 TIL PD-L1 TUMOR & TIL PD-L1 Age Low High P value R Pearson

Molecular Therapy - Oncolytics

MicroRNA-101 Inhibits Growth, Proliferation and Migration and Induces Apoptosis of Breast Cancer Cells by Targeting Sex-Determining Region Y-Box 2 Cell.

A B SK-N-SH cells, 24 h after irradiation SK-N-SH cells, 48 h

Supplementary FigureS4 (Feduska et al.)

Attema et al., Supplementary Figure 1

Supplementary Figure 2 Secondary transplanted brain tumors from PASC1 express human GH. Immuno-fluorescence staining of brain sections from mice implanted.

Fig. 6. AZD6738 induces DNA damage and apoptosis and exhibits antitumor efficacy in xenograft models of high-risk medulloblastoma and neuroblastoma. AZD6738.

Supplementary Table 1 Sequences of the primer used for q-PCR analysis

Figure S3. in vivo Study of ABT-263 or SAR in the RS4;11 model in mice

Grade one First term Second term Learning unit Learning unit

RASAL2: Wrestling in the Combat of Ras Activation

Volume 2, Issue 5, Pages (November 2002)

Supplementary Figure S1

Изразеното в настоящата презентация мнение обвързва единствено автора и не представлява официално становище на Комисията за финансов надзор Данил Джоргов.

Figure 2S (Supplementary Data)

Patients who have received chemotherapy (n=60)

Volume 19, Issue 12, Pages (June 2017)

Figure S2 Supplementary data a b CCA1 CCA2 CCA4 CCA3 CCA5 EGFR HER2

Disease-specific survival

Supplementary figure1. CK7 CK20 CDX2 DPEP1 Cut off value: 85%

A LAN6 CHLA90 CHLA15 SK-N-RA DMSO 13-cis RA

Supplementary Fig. S1 * * * * * * * * * * WS (µg/ml) + H2O2 (500 µM)

Fig. 4. BET inhibition sensitizes HR-proficient tumors to PARPi treatment in vivo. BET inhibition sensitizes HR-proficient tumors to PARPi treatment in.

A Humanized Stromal Bed Is Required for Engraftment of Isolated Human Primary Squamous Cell Carcinoma Cells in Immunocompromised Mice Girish K. Patel,

Volume 25, Issue 4, Pages e7 (April 2018)

Kun-Peng Zhu, Xiao-Long Ma, Chun-Lin Zhang Molecular Therapy

Volume 19, Issue 12, Pages (June 2017)

In vivo validation of effects of combination therapies on subpopulation composition. In vivo validation of effects of combination therapies on subpopulation.

Increase in beige/brown adipocyte characteristics in the xenografts from additional breast cancer cell lines. Increase in beige/brown adipocyte characteristics.

In vivo efficacy of Olaparib in PTEN deficient xenografts.

Volume 19, Issue 12, Pages (December 2011)

Supplemental Figure 6 Supplemental Figure 6. Treatment with erlotinib plus TAS-115 inhibits the growth of PC-9/HGF tumors in vivo. (A, B) Nude mice bearing.

Volume 142, Issue 2, Pages (July 2010)

Supplementary Figure 1 SK-N-SH Vehicle GW9662 Number of cells

Activity of MAC-321 (i. v. and p. o

Drugging MYCN through an Allosteric Transition in Aurora Kinase A

C A B * * * * HCC1954 HCC1569 Supplementary-Figure S5 Tumor cells sc.

2DG downregulates the expression of HIF-1α, PDK1 and c-Myc in NB xenograft. 2DG downregulates the expression of HIF-1α, PDK1 and c-Myc in NB xenograft.

Supplementary figure 1 A B Water (Control) Pre-alcohol Post-alcohol

Antitumor activity of HER2-lytic hybrid peptide in tumor xenograft model in vivo. Antitumor activity of HER2-lytic hybrid peptide in tumor xenograft model.

mTORC1 is required to prevent cellular senescence.

In vivo growth-inhibitory effect of perifosine on bevacizumab-resistant CCC. A, the effect of bevacizumab (BEV) on CCC growth in vivo. In vivo growth-inhibitory.

Matriptase-2 inhibited breast tumor development in vivo.

The effect of IAA on tumor growth in an SK-MEL-28 xenograft model.

Depletion of UCP1 and Myf5 population reduced xenograft growth.

In vivo tumorigenicity of MKN-1 cells with sustained suppression of HDAC2. In vivo tumorigenicity of MKN-1 cells with sustained suppression of HDAC2. A,

In vivo efficacy of targeted EDVTM in an orthotopic neuroblastoma mouse model with high EGFR protein levels. In vivo efficacy of targeted EDVTM in an orthotopic.

miR-100 suppresses bladder cancer cell growth in vitro and in vivo.

Comparison of in vivo activity of 4D5scFvZZ and 4D5scFv.

Targeting GAPLINC decreased CD44 expression and tumor growth in vivo.

In vivo tumor targeting and biodistribution of radiolabeled anti-CEA Fab-H-2Kb/ova conjugates. In vivo tumor targeting and biodistribution of radiolabeled.

Levels of neutrophil infiltration into gliomas correlate with tumor grades and tumor progression. Levels of neutrophil infiltration into gliomas correlate.

MYC expression is correlated with dasatinib sensitivity in cancer cell lines and in vivo. MYC expression is correlated with dasatinib sensitivity in cancer.

Mutation of the Smad3 linker phosphorylation sites in 4T1 cells reduces putative stem cell population and tumor initiating frequency of cells from the.

W. chinensis extract attenuates tumor growth of 103E (a subline of CWR22Rv1) engrafted in the prostate of nude mice. W. chinensis extract attenuates tumor.

PLK1 is a crucial downstream effector of PDK1 for MYC activation and cell survival. PLK1 is a crucial downstream effector of PDK1 for MYC activation and.

Schematic of models of N-MYC overexpression-driven genetically engineered mouse tumor models and human tissue recombination models. Schematic of models.

Figure 12a Pitfalls in N staging at CT and PET

PD-L1 expression is not associated with PTEN expression status in melanomas. PD-L1 expression is not associated with PTEN expression status in melanomas.

MYC is required for the hypoxic induction of SHMT2.

DHA and dietary n-3 PUFAs inhibit endometrial cancer cell growth in vitro and in xenograft models. DHA and dietary n-3 PUFAs inhibit endometrial cancer.

Presentation transcript:

palpable tumor in nudes N-myc amplify stage tumor site p53 status palpable tumor in nudes CHLA-20 - 4 F 4-10 weeks CHLA-90 BM N relapse CHLA-119 + 6 weeks CHLA-136 9-10 weeks CHP-134 adrenal, node 4 weeks IMR-32 unknown 8 weeks NB-1643 NB-EBc1 ND SK-N-AS 2 weeks SK-N-BE(2) 3-4 weeks SK-N-SH 5-6 weeks SH-SY5Y* Supplementary Figure S1. Neuroblastoma Cell Line Demographics. The 12 neuroblastoma cell lines used in the study. The four cell lines highlighted in yellow were selected for in vivo xenograft tumor models. * Subline of SK-N-SH Supplementary Figure S1. Neuroblastoma Cell Line Demographics. The 12 neuroblastoma cell lines used in the study. The four cell lines highlighted in yellow were selected for in vivo xenograft tumor models. * Subline of SK-N-SH